NCT05762185Completed
Interest of a Nursing Consultation in the Empowerment of the Patient With Rheumatoid Arthritis in the Management of His Subcutaneous Biotherapy
Source: ClinicalTrials.gov · Last updated 12 Jun 2026
Brief summary (registry, in English)
Biotherapy present specifics risks that patients must know and learn to manage. A national survey has been carried in this study to evaluate patients safety skills. (wording: " cross study of safety skills of 677 patients treat by biopharmaceuticals for an inflammatory rheumatism). This survey has allowed showcasing patients difficulties in managing their treatment, including for those under subcutaneous biotherapy. More than 60% patients interviewed doesn't know symptoms to bring them to consult and mainly postpone to their injection. The aim of this study is to prove that nursing consultation can allow the patient to become independent in treatment management and thus avoid occurrence of adverse event.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 71 (actual)
- First submitted
- 28 Feb 2023
- Start date
- 6 Nov 2019
- Primary completion date
- 13 Feb 2024
- Lead sponsor
- Centre Hospitalier Universitaire, Amiens
- Diseases
- Rheumatoid arthritis
- NCT number
- NCT05762185
What you commit to
- Study type: Interventional
- Participants enrolled: 71
- From 6 Nov 2019 to the primary completion date, 13 Feb 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patient with cognitive impairment diagnosed by a physician
Other
- Minor patient
- Patient under tutorship or curatorship
- Patient deaf or hard of hearing
- Patient not fluent in the French language (at the decision of the investigator)
Who the study is looking for
- Patient suffering from rheumatoid arthritis followed by Rheumatology consultation of Amiens-Picardie University Hospital
- Patient treated by Subcutaneous Biotherapy for at least 6 months at the time of inclusion
- Major patient
- Patient having signed an informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Chu Amiens Picardie Coordinator of this site? Confirm its status | Amiens | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.